Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Praziquantel (PZQ) is the only widely available drug to treat schistosomiasis. Given the potential for drug resistance, it is prudent to search for novel therapeutics. Identification of anti-schistosomal chemicals has traditionally relied on phenotypic (whole organism) screening with adult worms in vitro and/or animal models of disease-tools that limit automation and throughput with modern microtiter plate-formatted compound libraries. METHODS: A partially automated, three-component phenotypic screen workflow is presented that utilizes at its apex the schistosomular stage of the parasite adapted to a 96-well plate format with a throughput of 640 compounds per month. Hits that arise are subsequently screened in vitro against adult parasites and finally for efficacy in a murine model of disease. Two GO/NO GO criteria filters in the workflow prioritize hit compounds for tests in the animal disease model in accordance with a target drug profile that demands short-course oral therapy. The screen workflow was inaugurated with 2,160 chemically diverse natural and synthetic compounds, of which 821 are drugs already approved for human use. This affords a unique starting point to 'reposition' (re-profile) drugs as anti-schistosomals with potential savings in development timelines and costs. FINDINGS: Multiple and dynamic phenotypes could be categorized for schistosomula and adults in vitro, and a diverse set of 'hit' drugs and chemistries were identified, including anti-schistosomals, anthelmintics, antibiotics, and neuromodulators. Of those hits prioritized for tests in the animal disease model, a number of leads were identified, one of which compares reasonably well with PZQ in significantly decreasing worm and egg burdens, and disease-associated pathology. Data arising from the three components of the screen are posted online as a community resource. CONCLUSIONS: To accelerate the identification of novel anti-schistosomals, we have developed a partially automated screen workflow that interfaces schistosomula with microtiter plate-formatted compound libraries. The workflow has identified various compounds and drugs as hits in vitro and leads, with the prescribed oral efficacy, in vivo. Efforts to improve throughput, automation, and rigor of the screening workflow are ongoing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237 · cited 2×
“repositioning (re-profiling or re-purposing) [30] chemical entities as novel anti-schistosomals.”
BackgroundSteinmann, P., Keiser, J., Bos, R., Tanner, M., & Utzinger, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70521-7 · Cited by 2,156 · cited 1×
“Yet, reliance on a single drug to treat a population of over 200 million people infected and over 700 million people at risk over three continents [9] seems particularly perilous when considering the threat of drug resistance.”
BackgroundControl of Neglected Tropical Diseases
Hotez, P. J., Molyneux, D. H., Fenwick, A., Kumaresan, J., Sachs, S. E., Sachs, J. D., & Savioli, L. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064142 · Cited by 1,585
An Improved Perfusion Technique for Recovering Adult Schistosomes from Laboratory Animals
Duvall, R. H., & DeWitt, W. B. (1967) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1967.16.483 · Cited by 599 · cited 1×
“the hepatic portal system [34] in RPMI 1640 medium (Invitrogen, Carlsbad, CA).”
MethodOpportunities and Challenges in Antiparasitic Drug Discovery
Pink, R., Hudson, A., Mouriès, M.-A., & Bendig, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1824 · Cited by 545 · cited 1×
“[6].”
Innovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521 · cited 5×
“demand for short course oral chemotherapy [29].”
BackgroundMethodInfluentialPraziquantel, a new broad-spectrum antischistosomal agent
G�nnert, R., & Andrews, P. (1977) · Zeitschrift f�r Parasitenkunde · doi:10.1007/bf00389899 · Cited by 412 · cited 1×
“seems particularly perilous when considering the threat of drug resistance. Also, PZQ is not without problems. Principal among these is its relative inactivity against migratory juvenile and sub-adult worms”
BackgroundSchistosoma mansoni: Chemotherapy of infections of different ages
Sabah, A. A., Fletcher, C., Webbe, G., & Doenhoff, M. J. (1986) · Experimental Parasitology · doi:10.1016/0014-4894(86)90184-0 · Cited by 360 · cited 1×
“Principal among these is its relative inactivity against migratory juvenile and sub-adult worms [10,11] meaning that, for effective treatment and sustainable control, PZQ must be given on a regular basis.”
BackgroundThe biology and toxicology of molluscicides, bayluscide
Andrews, P., Thyssen, J., & Lorke, D. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90064-x · Cited by 347
Cioli, D., & Pica-Mattoccia, L. (2003) · Parasitology Research · doi:10.1007/s00436-002-0751-z · Cited by 343
Cited by
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Bergquist, R., Utzinger, J., & Keiser, J. (2017) · Infectious Diseases of Poverty · doi:10.1186/s40249-017-0286-2 · Cited by 195
“[85] tested a large number of natural and synthetic compounds against S.”
Background“Manifesto” for Advancing the Control and Elimination of Neglected Tropical Diseases
Hotez, P. J., & Pecoul, B. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000718 · Cited by 138
(2025) · doi:10.1073/pnas.2505710122 · Cited by 8
Metadata
- Authors
- Abdulla, M.-H., Ruelas, D. S., Wolff, B., Snedecor, J., Lim, K.-C., Xu, F., Renslo, A. R., Williams, J., McKerrow, J. H., & Caffrey, C. R.
- Venue
- PLoS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-07-14
- Volume
- 3
- Issue
- 7
- Pages
- e478
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W2055907171
- Cited by
- 224
- References
- 37
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening. https://app.cochat.ai/papers/10.1371/journal.pntd.0000478
- The paper
- Abdulla, M.-H., Ruelas, D. S., Wolff, B., Snedecor, J., Lim, K.-C., Xu, F., Renslo, A. R., Williams, J., McKerrow, J. H., & Caffrey, C. R. (2009). Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening. PLoS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0000478
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.